BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
Eli Lilly to Acquire Adverum Biotechnologies to Advance Gene Therapy for Wet AMD October 27, 2025 Eli Lilly will acquire Adverum Biotechnologies, including Ixo-vec, a Phase 3 gene therapy for wet age-related macular degeneration. The deal includes contingent value rights and pre-closing funding support.
HealthTap Partners with LillyDirect to Expand Virtual Primary Care for Diabetes Patients October 9, 2025 HealthTap has joined Eli Lilly’s LillyDirect platform as its first primary care provider, offering virtual consultations for diabetes patients. The partnership aims to improve access to holistic, continuous care for millions managing chronic conditions.
Eli Lilly to Invest $1 Bn in Hyderabad Contract Manufacturing & Oversight Facility October 7, 2025 Eli Lilly announces $1 billion investment in Hyderabad to expand contract manufacturing and oversight facilities, boosting employment and healthcare production capacity.
Eli Lilly Signs $1.3 Bn AI Deal August 18, 2025 Eli Lilly has partnered with Superluminal Medicines in a $1.3 billion deal to develop AI-driven obesity and heart disease drugs.
Lilly Launches Hyderabad Tech Hub to Power Global Digital Health Operations August 5, 2025 Eli Lilly launches a digital centre in Hyderabad focused on AI, cloud, and engineering to support global healthcare innovation and efficiency.
Eli Lilly to Establish Global Capability Centre in Hyderabad, Boosting Digital Innovation January 10, 2025 Pharma giant Eli Lilly announces a new capability centre in Hyderabad, set to hire over 1,000 skilled professionals, enhancing its global operations and innovation footprint in India.
Eli Lilly & OpenAI Partner to Leverage Gen AI for Combating AMR June 26, 2024 The collaboration aims to invent novel antimicrobials that can effectively combat drug-resistant pathogens.
Eli Lilly Inks Deal to Acquire Nexus Manufacturing Plant Amid Drug Shortages April 26, 2024 The move comes at a critical time as shortages of Mounjaro, a widely-used diabetes therapy, and Zepbound, its obesity counterpart, continue to impact patients across the United States.
Eli Lilly Launches Digital Healthcare Platform ‘LillyDirect’ to Help Patients with Chronic Illness January 5, 2024 LillyDirect offers access to independent healthcare providers, direct home delivery of specified Lilly medicines through third-party pharmacy dispensing services. It also provides access to LillyDirect Pharmacy Solutions—a digital pharmacy for consistent access to prescribed medications delivered directly to patients at their homes.
Page 1 of 1
